Metraipolis › archive › dc_7bab7d2a9bbc

Tolerability and Clinical Benefit Assessment of Continuous Roginolisib Administration in Patients with Cancer including Metastatic Uveal Melanoma — Europe PMC PPR:PPR1135152

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1135152
DOI
10.21203/rs.3.rs-8048398/v1
License (as archived)
solo-consultazione
Archived
2026-10-08T01:33:05.198Z
SHA-256 of the archived text
24bf71479ab874d29e58b38096db113ed69a36555b687379de0b86e97775edf5
Stable URL of this page
https://metraipolis.com/documento/dc_7bab7d2a9bbc

How to cite

Tolerability and Clinical Benefit Assessment of Continuous Roginolisib Administration in Patients with Cancer including Metastatic Uveal Melanoma — Europe PMC PPR:PPR1135152 — Europe PMC, https://europepmc.org/article/PPR/PPR1135152 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bab7d2a9bbc (Metraipolis archive dc_7bab7d2a9bbc, sha256 24bf71479ab874d29e58b38096db113ed69a36555b687379de0b86e97775edf5)
BibTeX
@misc{dc7bab7d2a9bbc,
  title = {Tolerability and Clinical Benefit Assessment of Continuous Roginolisib Administration in Patients with Cancer including Metastatic Uveal Melanoma — Europe PMC PPR:PPR1135152},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1135152},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bab7d2a9bbc; sha256 24bf71479ab874d29e58b38096db113ed69a36555b687379de0b86e97775edf5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1135152. Agents can read the archived copy with the MCP tool read_document.